fluoxetine and pirenzepine

fluoxetine has been researched along with pirenzepine in 35 studies

Research

Studies (35)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (11.43)	18.2507
2000's	29 (82.86)	29.6817
2010's	2 (5.71)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Epperson, CN; McDougle, CJ; Potenza, MN; Wasylink, S	1
Epperson, CN; Longhurst, JG; McDougle, CJ; Potenza, MN; Wasylink, S	1
de la Sablonnière, JF; Mottard, JP	1
Chau, D; Hoebel, BG; Kosloff, RA; Rada, PV	1
Heal, DJ; Kilpatrick, IC; Needham, PL; Rowley, HL	1
Elliott, MA; Koran, LM; Ringold, AL	1
Bao, J; Bymaster, FP; Perry, KW; Potts, BD; Tollefson, GD; Wong, DT; Zhang, W	1
Nelson, LA; Swartz, CM	1
Buras, WR; Bymaster, FP; Feldman, PD; Gannon, KS; Jacobs, TG; Meltzer, HY; Shelton, RC; Spencer, KA; Stahl, S; Tohen, M; Tollefson, GD; Zhang, W	1
Marsh, C; Preskorn, SH; Shad, MU	1
Farmer, A; Marusic, A	1
Hallett, J; Harel, Z; Kiessling, L; Riggs, S; Vaz, R	1
Gibson, PJ; Greaney, MG; Grundy, SL; Namjoshi, MA; Sanger, TM; Tohen, MF	1
Aldurra, G; Crayton, JW	1
Ashton, AK	1
Benazzi, F	1
Fuchs, C; Gil-Ad, I; Maayan, R; Pashinian, A; Poyurovsky, M; Schneidman, M; Weizman, A	1
de Suray, JM; Gangji, D; Gossen, D; Onkelinx, C; Vandenhende, F	1
Kline, NA; Matloff, JL; Stein, MB	1
Bottonari, KA; Dording, CM; Fava, M; Irvin, R; Matthews, JD; Mischoulon, D; Polania, LM	1
Safranko, I	1
Schatzberg, AF	1
Bogenschutz, M; Bustillo, JR; Hammond, R; Keith, S; Lauriello, J; Parker, K; Rowland, L	1
Bowden, CL	1
Shelton, RC	1
Detweiler, MB; Trinkle, DB	1
Gronier, BS; Rasmussen, K	1
Goyal, A; Hallas, BH; Horowitz, AT; Horowitz, JM; Ramdeen, N; Torres, G	1
Baker, RW; Beymer, K; Bowden, C; Breier, A; Calabrese, J; Centorrino, F; Dube, S; Evans, AR; Ketter, TA; Mitchell, PB; Risser, R; Sachs, G; Tohen, M; Tollefson, GD; Vieta, E	1
Andersen, SW; Corya, SA; Detke, HC; Dubé, S; Kelly, LS; Sanger, TM; Van Campen, LE; Williamson, DJ	1
Degroot, A; Nomikos, GG	1
Grundt, P; Katz, JL; Kopajtic, TA; Newman, AH	1
Dean, B; Gibbons, AS; Jeon, WJ; Scarr, E	1

Reviews

2 review(s) available for fluoxetine and pirenzepine

Article	Year
New approaches to managing psychotic depression. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 1 Topics: Affective Disorders, Psychotic; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Drug Therapy, Combination; Electroconvulsive Therapy; Fluoxetine; Humans; Lithium; Mifepristone; Olanzapine; Pirenzepine; Receptors, Glucocorticoid; Treatment Outcome	2003
The combination of olanzapine and fluoxetine in mood disorders. Expert opinion on pharmacotherapy, 2003, Volume: 4, Issue:7 Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Drug Therapy, Combination; Fluoxetine; Half-Life; Humans; Mood Disorders; Olanzapine; Pirenzepine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2003

Article

Year

New approaches to managing psychotic depression.

The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 1

Topics: Affective Disorders, Psychotic; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Drug Therapy, Combination; Electroconvulsive Therapy; Fluoxetine; Humans; Lithium; Mifepristone; Olanzapine; Pirenzepine; Receptors, Glucocorticoid; Treatment Outcome

2003

The combination of olanzapine and fluoxetine in mood disorders.

Expert opinion on pharmacotherapy, 2003, Volume: 4, Issue:7

Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Drug Therapy, Combination; Fluoxetine; Half-Life; Humans; Mood Disorders; Olanzapine; Pirenzepine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2003

Trials

10 trial(s) available for fluoxetine and pirenzepine

Article	Year
Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:7 Topics: Adult; Benzodiazepines; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Weight Gain; Xerostomia	2000
A novel augmentation strategy for treating resistant major depression. The American journal of psychiatry, 2001, Volume: 158, Issue:1 Topics: Ambulatory Care; Basal Ganglia Diseases; Benzodiazepines; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; Humans; Olanzapine; Pirenzepine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2001
Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:4 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep; Treatment Outcome; Weight Gain	2001
Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition. The American journal of psychiatry, 2002, Volume: 159, Issue:6 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Hospitalization; Humans; Male; Obesity; Olanzapine; Pirenzepine; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Weight Gain	2002
Influence of fluoxetine on olanzapine pharmacokinetics. AAPS pharmSci, 2002, Volume: 4, Issue:2 Topics: Adult; Antipsychotic Agents; Asthenia; Benzodiazepines; Cross-Over Studies; Depressive Disorder; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Olanzapine; Pirenzepine; Selective Serotonin Reuptake Inhibitors; Xerostomia	2002
Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. The American journal of psychiatry, 2002, Volume: 159, Issue:10 Topics: Antipsychotic Agents; Benzodiazepines; Combat Disorders; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; Humans; Male; Middle Aged; Olanzapine; Paroxetine; Pirenzepine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Wake Disorders; Treatment Outcome	2002
An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders	2002
Treatment of weight gain with fluoxetine in olanzapine-treated schizophrenic outpatients. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:3 Topics: Adolescent; Adult; Analysis of Variance; Benzodiazepines; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Olanzapine; Outpatients; Pirenzepine; Prospective Studies; Schizophrenia; Weight Gain	2003
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Archives of general psychiatry, 2003, Volume: 60, Issue:11 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Treatment Outcome	2003
Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:11 Topics: Adult; Benzodiazepines; Depressive Disorder; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	2003

Other Studies

23 other study(ies) available for fluoxetine and pirenzepine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Olanzapine augmentation of fluoxetine in the treatment of trichotillomania. The American journal of psychiatry, 1998, Volume: 155, Issue:9 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Fluoxetine; Humans; Olanzapine; Pirenzepine; Selective Serotonin Reuptake Inhibitors; Trichotillomania	1998
Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:5 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Retreatment; Selective Serotonin Reuptake Inhibitors; Treatment Failure	1998
Olanzapine-induced obsessive-compulsive disorder. The American journal of psychiatry, 1999, Volume: 156, Issue:5 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clomipramine; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Schizophrenia	1999
Cholinergic, M1 receptors in the nucleus accumbens mediate behavioral depression. A possible downstream target for fluoxetine. Annals of the New York Academy of Sciences, 1999, Jun-29, Volume: 877 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acetylcholine; Animals; Arecoline; Depression; Female; Fluoxetine; Microinjections; Motor Activity; Nucleus Accumbens; Pirenzepine; Posture; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptors, Muscarinic; Scopolamine; Swimming	1999
A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo. Naunyn-Schmiedeberg's archives of pharmacology, 2000, Volume: 361, Issue:2 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dibenzothiepins; Dopamine; Fluoxetine; Frontal Lobe; Haloperidol; Male; Microdialysis; Olanzapine; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Serotonin	2000
Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2000, Volume: 23, Issue:3 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Dopamine; Drug Synergism; Extracellular Space; Fluoxetine; Male; Microdialysis; Norepinephrine; Olanzapine; Pirenzepine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Stimulation, Chemical	2000
Melancholic symptoms during concurrent olanzapine and fluoxetine. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2000, Volume: 12, Issue:3 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzodiazepines; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Olanzapine; Pirenzepine	2000
The economic consequences of a drug-drug interaction. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:1 Topics: Aged; Antipsychotic Agents; Benzodiazepines; Depression; Drug Interactions; Female; Fluoxetine; Haloperidol; Health Care Costs; Humans; Olanzapine; Parkinson Disease; Pirenzepine; Selegiline; Trihexyphenidyl	2001
Antidepressant augmentation with low-dose olanzapine in obsessive-compulsive disorder. The British journal of psychiatry : the journal of mental science, 2000, Volume: 177 Topics: Antipsychotic Agents; Benzodiazepines; Drug Interactions; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine	2000
Antibodies against human putamen in adolescents with anorexia nervosa. The International journal of eating disorders, 2001, Volume: 29, Issue:4 Topics: Adolescent; Anorexia Nervosa; Antibodies; Benzodiazepines; Body Mass Index; Caudate Nucleus; Enzyme-Linked Immunosorbent Assay; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Putamen; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires	2001
Improvement of hallucinogen persisting perception disorder by treatment with a combination of fluoxetine and olanzapine: case report. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:3 Topics: Adolescent; Benzodiazepines; Drug Therapy, Combination; Fluoxetine; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Olanzapine; Pirenzepine; Psychoses, Substance-Induced; Selective Serotonin Reuptake Inhibitors	2001
Olanzapine augmentation for trichotillomania. The American journal of psychiatry, 2001, Volume: 158, Issue:11 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Olanzapine; Pirenzepine; Trichotillomania	2001
Fluoxetine and olanzapine for resistant depression. The American journal of psychiatry, 2002, Volume: 159, Issue:1 Topics: Benzodiazepines; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Fluoxetine; Humans; Metabolic Clearance Rate; Olanzapine; Pirenzepine; Randomized Controlled Trials as Topic; Treatment Outcome	2002
Reply to Dr Mahendran. We have not found reported cases of [obsessive-compulsive] OC arising from de novo with olanzapine treatment. The Australian and New Zealand journal of psychiatry, 2003, Volume: 37, Issue:1 Topics: Adult; Benzodiazepines; Clomipramine; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Schizophrenia	2003
Improving identification of treatment effectiveness in bipolar disorders. Bipolar disorders, 2003, Volume: 5, Issue:2 Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Fluoxetine; Humans; Olanzapine; Pirenzepine	2003
Fluoxetine augmentation with olanzapine for treatment of chronic resistant depression in an elderly patient: a case report. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:7 Topics: Aged; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Fluoxetine; Humans; Male; Olanzapine; Pirenzepine	2003
Electrophysiological effects of acute and chronic olanzapine and fluoxetine in the rat prefrontal cortex. Neuroscience letters, 2003, Oct-09, Volume: 349, Issue:3 Topics: Action Potentials; Animals; Benzodiazepines; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Fluoxetine; Male; Neural Pathways; Neurons; Olanzapine; Pirenzepine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Schizophrenia; Selective Serotonin Reuptake Inhibitors	2003
Characterization of fluoxetine plus olanzapine treatment in rats: a behavior, endocrine, and immediate-early gene expression analysis. Synapse (New York, N.Y.), 2003, Dec-15, Volume: 50, Issue:4 Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Blood Glucose; Blotting, Western; Body Weight; Corticosterone; Cyclic AMP Response Element-Binding Protein; Drug Interactions; Fluoxetine; Gene Expression; Genes, Immediate-Early; Hippocampus; Immunohistochemistry; Male; Mitogen-Activated Protein Kinases; Movement; Olanzapine; Pirenzepine; Proto-Oncogene Proteins c-fos; Rats; Rats, Long-Evans; Time Factors	2003
Fluoxetine disrupts the integration of anxiety and aversive memories. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:2 Topics: Acetylcholine; Animals; Antidepressive Agents, Second-Generation; Anxiety; Dose-Response Relationship, Drug; Electroshock; Fluoxetine; Hippocampus; Male; Memory; Memory, Short-Term; Microdialysis; Muscarinic Antagonists; Parasympathetic Nervous System; Pirenzepine; Rats; Rats, Sprague-Dawley; Synaptic Transmission	2005
N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands. Bioorganic & medicinal chemistry letters, 2005, Dec-15, Volume: 15, Issue:24 Topics: Amines; Benztropine; Binding Sites; Citalopram; Cocaine; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; Kinetics; Ligands; Models, Molecular; Molecular Conformation; Muscarinic Antagonists; Parasympatholytics; Pirenzepine	2005
Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and Antidepressants. The international journal of neuropsychopharmacology, 2016, Volume: 19, Issue:4 Topics: Animals; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Cerebral Cortex; Depressive Disorder, Major; Disease Models, Animal; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged; Muscarinic Agonists; Oxotremorine; Pirenzepine; Radiopharmaceuticals; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Tritium	2016